[Correspondence] Can defective interfering RNAs affect the live attenuated influenza vaccine? – Authors' reply
We thank Nigel Dimmock and Andrew Easton for drawing attention to new research, which has become available since the publication of our article,1 describing their interesting observation of defective interfering RNAs in two batches of Fluenz Tetra (MedImmune, Nijmegen, Netherlands; AstraZeneca, Luton, UK) for the 2014 –15 influenza season.2 This research warrants further investigation to understand its implications.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Anika Singanayagam, Maria Zambon, Ajit Lalvani, Wendy Barclay Tags: Correspondence Source Type: research
More News: AstraZeneca | Infectious Diseases | Influenza | Influenza Vaccine | Netherlands Health | Vaccines